我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的隐私政策。
相关临床试验
42
18 进行中
药物批准
0
批准总数
监管机构
监管机构数
成立时间
1997
进行中（未招募）
1
2.4%
已完成
13
30.9%
Enrolling By Invitation
2
4.8%
尚未招募
15
35.7%
招募中
6
14.3%
Unknown
5
11.9%
暂无批准数据
- Groundbreaking research reveals patients with chronic lymphocytic leukemia or small lymphocytic lymphoma taking statins showed 61% lower cancer mortality and 38% reduced all-cause mortality when receiving targeted therapies like ibrutinib. - The collaborative study analyzed data from 1,467 patients across four international clinical trials conducted between 2012-2019, finding statin use was also associated with 26% lower disease progression without increasing severe side effects. - Researchers from University of Sharjah and Burjeel Cancer Institute caution that while promising, these observational findings require confirmation through dedicated clinical trials before statins can be recommended as supportive cancer treatment.
